Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Significance: This study suggests, for the first time, that Agaricus blazei Murill, by suppressing the expression of its target gene, it may increase the expression of PDLIM5. Thereby, it may inhibit pulmonary hypertension. Together, pharmacological formulations encompassing “Agaricus blazei Murill or small molecule compounds isolated from Agaricus blazei Murill“ may be used to treat pulmonary arterial hypertension (PAH).
Amount: $ 500*
Undisclosed information: How Agaricus blazei Murill increases the expression of PDLIM5
To cite: Boominathan, Natural product-based therapy for Pulmonary Hypertension (PAH): Agaricus blazei Murill inhibits pulmonary hypertension via induction of PDLIM5, 7/February/2015, 07.50 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org